Showing results (101-110 of 175) with videos related to

Sort By:
Pageof 18
Journal of Viral Hepatitis|May 11, 2019
Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C-SCOPE StudyAlain H Litwin, Martine Drolet, Chizoba Nwankwo, et al.
Preventive Medicine Reports|March 19, 2026
Implementation and costs of a food insecurity resource navigation program for primary care patients with diabetes and hypertension in South CarolinaDeeksha Gupta, Darin Thomas, Stella Self, et al.
Open Forum Infectious Diseases|October 25, 2021
Hepatitis C Resistance-Associated Substitutions Among People Who Inject Drugs Treated With Direct-Acting Antiviral-Containing RegimensMatthew J Akiyama, Lindsey Riback, Jacqueline D Reeves, et al.
The International Journal on Drug Policy|August 17, 2017
High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinicBrianna L Norton, Julia Fleming, Marcus A Bachhuber, et al.
Prehospital Emergency Care|January 13, 2025
Barriers to Buprenorphine: A Case Series of Misadventures Implementing a Prehospital Buprenorphine ProtocolParker Bailes Iv, Mirinda Ann Gormley, Sarah B Floyd, et al.
BMC Infectious Diseases|February 11, 2018
Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapyMatthew J Akiyama, Linda Agyemang, Julia H Arnsten, et al.
Lancet Regional Health. Americas|December 21, 2023
Implementation of a mobile health clinic framework for Hepatitis C virus screening and treatment: a descriptive studyLior Rennert, Kerry A Howard, Caitlin M Kickham, et al.
International Journal of Environmental Research and Public Health|May 27, 2023
Association between Initial Opioid Prescription and Patient Pain with Continued Opioid Use among Opioid-Naïve Patients Undergoing Elective Surgery in a Large American Health SystemAbass Babatunde, Lior Rennert, Kevin B Walker, et al.
The Journal of Infectious Diseases|March 10, 2020
A Phylogenetic Analysis of Hepatitis C Virus Transmission, Relapse, and Reinfection Among People Who Inject Drugs Receiving Opioid Agonist TherapyMatthew J Akiyama, Daniel Lipsey, Lilia Ganova-Raeva, et al.
The International Journal on Drug Policy|November 27, 2018
Perceptions and self-reported competency related to testing, management and treatment of hepatitis C virus infection among physicians prescribing opioid agonist treatment: The C-SCOPE studyJason Grebely, Martine Drolet, Chizoba Nwankwo, et al.
Pageof 18